Clinical Trial

The Franciscus Obesity NASH Study

Study acronym: FONS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) changes in terms of steatosis and elasticity in patients with morbid obesity 1, 3 and 5 years after bariatric surgery. In addition, genomics, microbiome and metabolomics analyses will be carried out.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-08-11.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-20
Trial Details
NCT Number NCT05499949
Lead Sponsor Franciscus Gasthuis
Collaborators: Amsterdam UMC, Erasmus Medical Center, Leiden University Medical Center
Conditions NAFLD, NASH - Nonalcoholic Steatohepatitis, Obesity, Morbid
Enrollment 300 participants
Start Date 2022-09-01
Primary Completion 2023-09-01 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-27